Northwestern Mutual Wealth Management’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
Other funds holding CYCN
TCP
SL
TRCT
Northwestern Mutual Wealth Management's CYCN Position: Q2 2025 in Review
Northwestern Mutual Wealth Management sold out of Cyclerion Therapeutics (CYCN) in Q2 2025, closing a stake of 1 share — an estimated $3 sold.
Northwestern Mutual Wealth Management first reported a position in CYCN in Q2 2019 and held it in 24 quarters. The position peaked at $2K in Q3 2019. 17 funds tracked by Wall St. Rank hold CYCN as of Q2 2025.
- Northwestern Mutual Wealth Management reported no remaining Cyclerion Therapeutics position as of Q2 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 1 Cyclerion Therapeutics share in Q2 2025, an estimated $3.
- Northwestern Mutual Wealth Management first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 24 quarters.
- Northwestern Mutual Wealth Management's Cyclerion Therapeutics position peaked at $2K in Q3 2019.
- 17 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.